As pharmaceutical and biotech companies continue to move away from traditional glass packaging, Equinox® Syringesare emerging as a next-generation solution for safe, reliable and flexible pre-filled drug delivery across a wide range of medical and biological applications.
Designed as silicone-free, glass-replacement pre-filled plastic syringes, Equinox® Syringes address key challenges associated with conventional glass systems, including breakage risk, particulate contamination and drug–container interaction. The result is a delivery platform that supports both drug integrity and patient safety, particularly for sensitive and high-value therapeutics.
Advanced Polymer Technology for Modern Medicines
Equinox® Syringes are manufactured using high-performance polymers such as Cyclic Olefin Copolymer (COC) and Cyclic Olefin Polymer (COP) , materials increasingly preferred in parenteral packaging for their superior functional properties.
These advanced resins provide:
- Excellent barrier protection against moisture and oxygen
- High chemical resistance to ensure formulation stability
- Exceptional transparency for visual inspection and dosing accuracy
Together, these attributes make Equinox® Syringes especially suitable for biologics and other sensitive pharmaceutical compounds, where maintaining stability and efficacy throughout the product lifecycle is critical.
Optimised for Biologics and Sensitive Formulations
With biologics, proteins and complex injectable drugs gaining prominence, packaging reliability has become as important as formulation science. Equinox® Syringes are engineered to support the safe and effective delivery of biological compounds, reducing the risk of contamination while preserving therapeutic performance.
Their silicone-free design helps eliminate issues such as protein aggregation or interaction with lubricants, a growing concern in advanced injectable therapies.
Customisation and Flexibility Built In
Beyond material performance, Equinox® Syringes stand out for their high level of customisation. The manufacturing process is designed to adapt to the unique requirements of each application, ensuring optimal syringe design for different drug delivery needs.
Unlike many suppliers, Equinox® is not limited to one or two polymer options. Syringes can be produced using a variety of resins, allowing customers to select the most appropriate material based on formulation compatibility, regulatory requirements and performance goals.
Supporting Clinical Trials and Early-Stage Development
Equinox® Syringes can also be supplied in small batch quantities, making them ideal for new drug development, pilot programs and clinical trials. This flexibility enables pharmaceutical and biotech companies to evaluate, test and refine their products without the constraints of large-scale minimum order volumes.
A Future-Ready Drug Delivery Platform
By combining advanced polymer science, silicone-free design, custom manufacturing and small-batch availability, Equinox® Syringes represent a future-ready solution for injectable drug delivery. As the industry continues to shift toward biologics and precision therapies, Equinox® offers a dependable platform that aligns with evolving regulatory, safety and performance expectations.